28277099|t|CD169 is a marker for highly pathogenic phagocytes in multiple sclerosis
28277099|a|Phagocytes, such as macrophages and microglia, are key effector cells in the pathophysiology of multiple sclerosis (MS). It is widely accepted that they instigate and promote neuroinflammatory and neurodegenerative events in MS. An increasing amount of studies indicate that Siglec-1, also known CD169, is a marker for activated phagocytes in inflammatory disorders. In this study, we set out to define how CD169(+) phagocytes contribute to neuroinflammation in MS. CD169 - diphtheria toxin receptor (DTR) mice, which express human DTR under control of the CD169 promoter, were used to define the impact of CD169(+) cells on neuroinflammation. Flow cytometry and immunohistochemistry were utilized to determine the expression and distribution of CD169. We show that CD169 is highly expressed by lesional and circulating phagocytes in MS and experimental autoimmune encephalomyelitis (EAE). Our data further indicate that CD169 represents a selective marker for early activated microglia in MS and EAE lesions. Depletion of CD169(+) cells markedly reduced neuroinflammation and ameliorated disease symptoms in EAE - affected mice. Our findings indicate that CD169(+) cells promote neuroinflammation. Furthermore, they suggest that CD169(+) phagocytes play a key role in the pathophysiology of MS. Hence, targeting CD169(+) phagocytes may hold therapeutic value for MS.
28277099	0	5	CD169	T103	UMLS:C0142251
28277099	11	17	marker	T201	UMLS:C0005516
28277099	40	50	phagocytes	T017	UMLS:C0031307
28277099	54	72	multiple sclerosis	T038	UMLS:C0026769
28277099	73	83	Phagocytes	T017	UMLS:C0031307
28277099	93	104	macrophages	T017	UMLS:C0024432
28277099	109	118	microglia	T017	UMLS:C0206116
28277099	128	142	effector cells	T017	UMLS:C0312740
28277099	169	187	multiple sclerosis	T038	UMLS:C0026769
28277099	189	191	MS	T038	UMLS:C0026769
28277099	270	287	neurodegenerative	T038	UMLS:C0027746
28277099	298	300	MS	T038	UMLS:C0026769
28277099	326	333	studies	T062	UMLS:C2603343
28277099	348	356	Siglec-1	T103	UMLS:C0142251
28277099	369	374	CD169	T103	UMLS:C0142251
28277099	381	387	marker	T201	UMLS:C0005516
28277099	402	412	phagocytes	T017	UMLS:C0031307
28277099	416	438	inflammatory disorders	T038	UMLS:C1290884
28277099	448	453	study	T062	UMLS:C2603343
28277099	480	488	CD169(+)	T103	UMLS:C0142251
28277099	489	499	phagocytes	T017	UMLS:C0031307
28277099	514	531	neuroinflammation	T038	UMLS:C0021368
28277099	535	537	MS	T038	UMLS:C0026769
28277099	539	544	CD169	T103	UMLS:C0142251
28277099	547	572	diphtheria toxin receptor	T103	UMLS:C0058402
28277099	574	577	DTR	T103	UMLS:C0058402
28277099	579	583	mice	T204	UMLS:C0025929
28277099	599	604	human	T204	UMLS:C0086418
28277099	605	608	DTR	T103	UMLS:C0058402
28277099	630	635	CD169	T017	UMLS:C1420266
28277099	636	644	promoter	T103	UMLS:C0086860
28277099	680	688	CD169(+)	T103	UMLS:C0142251
28277099	689	694	cells	T017	UMLS:C0007634
28277099	698	715	neuroinflammation	T038	UMLS:C0021368
28277099	717	731	Flow cytometry	T058	UMLS:C0016263
28277099	736	756	immunohistochemistry	T058	UMLS:C0021044
28277099	819	824	CD169	T103	UMLS:C0142251
28277099	839	844	CD169	T103	UMLS:C0142251
28277099	868	876	lesional	T033	UMLS:C0221198
28277099	881	892	circulating	T038	UMLS:C1516559
28277099	893	903	phagocytes	T017	UMLS:C0031307
28277099	907	909	MS	T038	UMLS:C0026769
28277099	914	955	experimental autoimmune encephalomyelitis	T038	UMLS:C0014072
28277099	957	960	EAE	T038	UMLS:C0014072
28277099	994	999	CD169	T103	UMLS:C0142251
28277099	1023	1029	marker	T201	UMLS:C0005516
28277099	1040	1059	activated microglia	T017	UMLS:C0206116
28277099	1063	1065	MS	T038	UMLS:C0026769
28277099	1070	1073	EAE	T038	UMLS:C0014072
28277099	1074	1081	lesions	T033	UMLS:C0221198
28277099	1096	1104	CD169(+)	T103	UMLS:C0142251
28277099	1105	1110	cells	T017	UMLS:C0007634
28277099	1128	1145	neuroinflammation	T038	UMLS:C0021368
28277099	1162	1169	disease	T038	UMLS:C0012634
28277099	1170	1178	symptoms	T033	UMLS:C1457887
28277099	1182	1185	EAE	T038	UMLS:C0014072
28277099	1197	1201	mice	T204	UMLS:C0025929
28277099	1207	1215	findings	T033	UMLS:C0243095
28277099	1230	1238	CD169(+)	T103	UMLS:C0142251
28277099	1253	1270	neuroinflammation	T038	UMLS:C0021368
28277099	1303	1311	CD169(+)	T103	UMLS:C0142251
28277099	1312	1322	phagocytes	T017	UMLS:C0031307
28277099	1323	1327	play	T033	UMLS:C0600138
28277099	1365	1367	MS	T038	UMLS:C0026769
28277099	1386	1394	CD169(+)	T103	UMLS:C0142251
28277099	1395	1405	phagocytes	T017	UMLS:C0031307
28277099	1437	1439	MS	T038	UMLS:C0026769